Patients who received high-intensity statin therapy had a 23% elevated risk for developing type 2 diabetes (T2D) compared to those on low-intensity statins, the results of a large study showed. In ...
Lifetime treatment with statins is a cost-effective therapy across a wide range of elderly patients with and without cardiovascular disease, according to an analysis published this week in Heart.
How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results